Kinh doanh mạo hiểm: Nhận thức rủi ro và việc sử dụng dịch vụ y tế của khách hàng xét nghiệm di truyền cá nhân trực tiếp
Tóm tắt
Từ khóa
Tài liệu tham khảo
23andMe. 23andMe receives funding from the national institutes of health to evaluate web‐based research on the genetics of drug response. in 23andMe. Available athttps://www.23andme.com/about/press/20101216/.
Bloss C. S. Darst B. F. Topol E. J. &Schork N. J.(2011).Direct‐to‐consumer personalized genomic testing.Human Molecular Genetics. epub ahead of print.
Coriell Personalized Medicine Coalition. (2011). “Sample accounts”. Webpagehttp://cpmc.coriell.org/Demo/DemoPeople.aspxLast visited December 17 2011.
Gollust S. E. Gordon E. S. Zayac C. Griffin G. Christman M. F. Pyeritz R. E. et al. (2011).Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants.Public Health Genomics. epub ahead of print.
GPPC(2011).DTC table.Genetics and public policy center. Available fromhttp://www.dnapolicy.org/resources/DTCTableAug2011Alphabydisease.pdf.
Kutz G.(2010).Direct‐to‐consumer genetic tests: misleading test results are further complicated by deceptive marketing and other questionable practices.Congressional Testimony. July 22 2010.http://www.gao.gov/new.items/d10847t.pdf.
Leighton J. W. Valverde K. &Bernhardt B. A.(2011).The general public's understanding and perception of direct‐to‐consumer genetic test results.Public Health Genomicsepub ahead of print.
MarteauT. M. French D. P. Griffin S. J. Prevost A. T. Sutton S. Watkinson C. et al. (2010).Effects of communicating DNA‐based disease risk estimates on risk‐reducing behaviours.Cochrane Database of Systematic Reviews (10).